Your browser doesn't support javascript.
loading
Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration.
Lee, Jeong Hyun; Sutton, Henry J; Cottrell, Christopher A; Phung, Ivy; Ozorowski, Gabriel; Sewall, Leigh M; Nedellec, Rebecca; Nakao, Catherine; Silva, Murillo; Richey, Sara T; Torres, Jonathan L; Lee, Wen-Hsin; Georgeson, Erik; Kubitz, Michael; Hodges, Sam; Mullen, Tina-Marie; Adachi, Yumiko; Cirelli, Kimberly M; Kaur, Amitinder; Allers, Carolina; Fahlberg, Marissa; Grasperge, Brooke F; Dufour, Jason P; Schiro, Faith; Aye, Pyone P; Kalyuzhniy, Oleksandr; Liguori, Alessia; Carnathan, Diane G; Silvestri, Guido; Shen, Xiaoying; Montefiori, David C; Veazey, Ronald S; Ward, Andrew B; Hangartner, Lars; Burton, Dennis R; Irvine, Darrell J; Schief, William R; Crotty, Shane.
Afiliación
  • Lee JH; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Sutton HJ; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Cottrell CA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Phung I; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Ozorowski G; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Sewall LM; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Nedellec R; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Nakao C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Silva M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Richey ST; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Torres JL; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.
  • Lee WH; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Georgeson E; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Kubitz M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Hodges S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Mullen TM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Adachi Y; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Cirelli KM; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Kaur A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Allers C; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Fahlberg M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Grasperge BF; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Dufour JP; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Schiro F; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Aye PP; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Kalyuzhniy O; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Liguori A; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Carnathan DG; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Silvestri G; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Shen X; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Montefiori DC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Veazey RS; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Hangartner L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Burton DR; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Irvine DJ; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Crotty S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Nature ; 614(7949): E43, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36717721
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article